Substance Abuse Technologies to restructure:
This article was originally published in Clinica
Executive Summary
Substance Abuse Technologies will continue its operations while attempting to restructure, having filed for Chapter 11 bankruptcy protection. The beleaguered company has received loans from two of its largest shareholders. However, a SAT subsidiary, US Drug Testing, is suspending development of its saliva-based drugs-of-abuse and alcohol testing devices. It says attempts to seek alternative funding when SAT failed have been unsuccessful.